Results 11 to 20 of about 193,929 (276)
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy [PDF]
A paradigm shift has recently occurred in the field of cancer therapeutics. Traditional anticancer agents, such as chemotherapy, radiotherapy and small-molecule drugs targeting specific signalling pathways, have been joined by cellular immunotherapies based on T cell engineering.
Emma C. Morris +3 more
openaire +4 more sources
Cytokine release syndrome and tumor lysis syndrome in a multiple myeloma patient treated with palliative radiotherapy: A case report and review of the literature [PDF]
We present the case of a 53-year-old woman treated with analgesic radiotherapy for a multiple myeloma bone lesion of the forearm. After a first fraction of 5 Gray (Gy), she presented with an acute respiratory syndrome with fever a few hours after the ...
Axel Cailleteau +5 more
doaj +2 more sources
Editorial: Cytokine Release Syndrome in COVID-19: Mechanisms and Management [PDF]
Tao Hu
doaj +2 more sources
An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapies. [PDF]
Mazein A +16 more
europepmc +2 more sources
Cytokine Release Syndrome Following Blinatumomab Therapy [PDF]
New therapeutic solutions have emerged in the last few decades with the growth and expansion of the field of cancer research. Amongst these new agents, immunotherapy has been prominent, particularly regarding the treatment of hematologic malignancies.
Ojemolon, Pius E +4 more
openaire +2 more sources
Introduction Patients with coronavirus disease, especially solid organ transplant recipients, are more susceptible to developing cytokine release syndrome than those with other viral infections.
Daiji Takamoto +9 more
doaj +1 more source
Chimeric antigen receptor T (CAR-T) cell treatment is a rapidly emerging therapy for relapsed/refractory hematologic malignancies. Although cytokine release syndrome is a common complication, a concomitant development of biopsy-proven collapsing ...
Ratna Acharya +3 more
doaj +1 more source
Combined IVIG and High-Dose Systemic Corticosteroids for the Management of Pembrolizumab-Induced Cytokine Release Syndrome in Lung Adenocarcinoma. [PDF]
Liu CY, Liu CH.
europepmc +3 more sources
Сytokine release syndrome is the common complication of CAR-T therapy. We report a case of patient with B-cell acute lymphoblastic leukemia developing сytokine release syndrome with shock and multiple organ failure and requiring cytokine removal and ...
Antonina E. Shchekina +9 more
doaj +1 more source

